BOT 2.56% 40.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-5567

  1. 319 Posts.
    lightbulb Created with Sketch. 178
    The EH report from April where they listed target share price at 28c they included a go-to-market scenario that peaked at 3% market share, with US$934 million net sales. It’s now 33c.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.